Stock 4128MICROBIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Microbio Co., Ltd. Stock

Equities

4128

TW0004128004

Food Processing

End-of-day quote Taipei Exchange
Other stock markets
 2025-03-19 		5-day change 1st Jan Change
30.30 TWD -0.66% Intraday chart for Microbio Co., Ltd. -4.87% -8.18%
Mar. 17 Microbio Announces Promising Results Of MS-20 As Add-On Therapy For Ulcerative Colitis RE
Mar. 17 Microbio Co., Ltd. Announces Promising Results of MS-20 as an Add-on Therapy for Ulcerative Colitis CI

Valuation: Microbio Co., Ltd.

Capitalization 17.82B 540M 494M 473M 415M 772M 46.69B 849M 5.42B 2.06B 19.8B 2.02B 1.98B 80.74B P/E ratio 2023
-23.9x
P/E ratio 2024 -17.6x
Enterprise value 15.88B 481M 440M 422M 370M 688M 41.61B 756M 4.83B 1.84B 17.65B 1.8B 1.77B 71.96B EV / Sales 2023
15.9x
EV / Sales 2024 10.1x
Free-Float
66.98%
Yield 2023 *
-
Yield 2024 -
More valuation ratios * Estimated data

Chart: Microbio Co., Ltd.

Dynamic Chart

Latest news: Microbio Co., Ltd.

Microbio Announces Promising Results Of MS-20 As Add-On Therapy For Ulcerative Colitis Mar. 17 RE
Microbio Co., Ltd. Announces Promising Results of MS-20 as an Add-on Therapy for Ulcerative Colitis Mar. 17 CI
Microbio Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 Mar. 10 CI
Microbio Co., Ltd. Announces Promising Results of MS-20 in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer Dec. 16 CI
Microbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 Nov. 13 CI
Microbio Co., Ltd. Announces SNS812 Phase 2 Study Demonstrated Statistical Significance in Treating Covid-19 Based on Its Safety, Precision and Broad-Spectrum Efficacy by Its Subsidiary Microbio Co.,Ltd 24-09-08 CI
Microbio Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 24-08-11 CI
Microbio Co., Ltd. Announces the Finding on MS-20 Combined with Anti-PD1 Antibody Enhancing the Cancer Treatment Response 24-07-31 CI
Microbio Co., Ltd. Announces Change of the General Manager 24-06-11 CI
Microbio Co., Ltd. Announces Change of Remuneration Committee 24-05-30 CI
Microbio Co., Ltd. Announces Change of Chairperson of the Board of Directors 24-05-30 CI
Microbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 24-05-15 CI
Microbio Co., Ltd. Announces Withdrawal of 510(K) Application of MB107cream Medical Device 24-05-12 CI
More news

Press Releases: Microbio Co., Ltd.

Microbio : Announce on behalf of major subsidiary Cotton Field Organic Co., Ltd.on matters related to the full non-physical issuance of shares 22-08-17 PU
Microbio : Announce on behalf of major subsidiary Cotton Field Organic Co., Ltd. about the resolution that the Ex-rights record date of new shares from earnings by BOD 22-08-17 PU
Microbio : Announcement of the BOD resolved to release of non-compete restrictions for the manager 22-08-12 PU
Microbio : Annouce the new appointment of the general manager 22-08-12 PU
Microbio : The Board of Directors Approved the 2022 Q2 Consolidated Financial Statements 22-08-12 PU
More press releases

Quotes and Performance

1 day-0.66%
1 week-4.87%
Current month-7.06%
1 month-8.32%
3 months-11.92%
6 months-25.37%
Current year-8.18%
More quotes

Course Extremes

1 week
30.25
Extreme 30.25
31.95
1 month
30.2
Extreme 30.2
35.25
Current year
29.5
Extreme 29.5
35.65
1 year
29.5
Extreme 29.5
45.48
3 years
29.5
Extreme 29.5
70.65
5 years
8.81
Extreme 8.8078
115.15
10 years
8.41
Extreme 8.4107
115.15
More quotes

Managers and Directors: Microbio Co., Ltd.

Manager TitleAgeSince
Ming Lian Kuo CEO
 Chief Executive Officer - 2021-12-19
Ying Chun Wang DFI
 Director of Finance/CFO - 2015-02-28
Ke Hsiang Chou CTO
 Chief Tech/Sci/R&D Officer - 2008-06-30
Director TitleAgeSince
Yuan Ho Lai BRD
 Director/Board Member 85 2011-02-13
Kao Chung Tsai BRD
 Director/Board Member 63 2006-05-28
Hsien Shou Kuo CHM
 Chairman 83 2021-12-19
More insiders

ETFs: Microbio Co., Ltd.

Name Weight AuM 1st Jan change
LEADERSHARES EQUITY SKEW ETF - USD ETF LeaderShares Equity Skew ETF - USD
0.01% 89 M€ -5.41% -
DEMOCRACY INTERNATIONAL FUND ETF - USD ETF Democracy International Fund ETF - USD
0% 9 M€ +8.22% -
More ETFs: Microbio Co., Ltd.

Special Foods & Wellbeing Products

Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi.($)
MICROBIO CO., LTD. Stock Microbio Co., Ltd.
-0.66%-4.87%-26.44%-39.53% 543M
ZHEJIANG NHU COMPANY LTD. Stock Zhejiang NHU Company Ltd.
-0.64%-1.62%+24.96%-21.50% 9.34B
BELLRING BRANDS, INC. Stock BellRing Brands, Inc.
+0.77%+1.31%+13.53%+187.36% 8.78B
CSPC INNOVATION PHARMACEUTICAL CO., LTD. Stock CSPC Innovation Pharmaceutical Co., Ltd.
-0.18%+0.08%+11.43%+443.65% 7.33B
THE SIMPLY GOOD FOODS COMPANY Stock The Simply Good Foods Company
-0.92%-5.91%-7.72%-10.91% 3.37B
BYHEALTH CO., LTD Stock Byhealth Co., Ltd
-0.41%+1.24%-28.69%-44.26% 2.87B
XIAMEN KINGDOMWAY GROUP COMPANY Stock Xiamen Kingdomway Group Company
-0.65%+6.35%+6.21%-50.60% 1.29B
SIRIO PHARMA CO., LTD. Stock Sirio Pharma Co., Ltd.
-1.17%+2.80%+0.89%+20.35% 916M
JAMIESON WELLNESS INC. Stock Jamieson Wellness Inc.
+3.07%+4.02%+15.05%-19.02% 840M
HERBALIFE LTD. Stock Herbalife Ltd.
-4.21%-8.47%-9.94%-76.58% 829M
Average -0.51%-0.14%-0.07%+38.90% 3.61B
Weighted average by Cap. -0.23%+0.96%+9.03%+121.41%
See all sector performances

Financials

2023 2024
Net sales 1.59B 48.19M 44.08M 42.27M 37.09M 68.93M 4.17B 75.78M 484M 184M 1.77B 181M 177M 7.21B 1.72B 52.17M 47.72M 45.77M 40.15M 74.63M 4.51B 82.04M 524M 200M 1.91B 196M 192M 7.8B
Net income -1.18B -35.73M -32.68M -31.34M -27.5M -51.11M -3.09B -56.19M -359M -137M -1.31B -134M -131M -5.35B -1.1B -33.34M -30.49M -29.24M -25.66M -47.68M -2.88B -52.42M -335M -127M -1.22B -125M -122M -4.99B
Net Debt -3.02B -91.38M -83.59M -80.16M -70.33M -131M -7.91B -144M -918M -349M -3.35B -343M -336M -13.67B -1.94B -58.65M -53.65M -51.45M -45.14M -83.89M -5.07B -92.23M -589M -224M -2.15B -220M -215M -8.77B
More financial data * Estimated data

Company Profile

Logo Microbio Co., Ltd.
Microbio Co., Ltd. is a Taiwan-based company primarily engaged in the research, development, manufacture, distribution and wholesales of healthcare food products and pharmaceuticals. The Company provides fermentation products, including Tien Chun Bao (TCB) oral solutions; herbal products, including LeeHerb series products, as well as organic foods, including vegetables, fruits, nuts, pastry, seasonings, organic meals and others. In addition, it provides new medicines, including anticancer medicines, medicines for hepatitis, allergy, rheumatoid arthritis and others. The Company mainly distributes its products mainly within domestic market.
Employees
-
Sector
Food Processing
Calendar
May. 07 - Q1 2025 Earnings Release (Projected)
More about the company

Quotes

Date Price Change Volume
25-03-18 30.30 NT$ -0.66% 692,058
25-03-18 30.50 NT$ +0.33% 618,978
25-03-17 30.40 NT$ -0.49% 596,777
25-03-14 30.55 NT$ -0.49% 620,633
25-03-13 30.70 NT$ -2.69% 836,797

End-of-day quote Taipei Exchange, March 18, 2025

More quotes

Income Statement and Estimates

More financial data
  1. Stock Market
  2. Equities
  3. 4128 Stock